Second near-infrared light-activatable polymeric nanoantagonist for photothermal immunometabolic cancer therapy
Immunometabolic modulation offers new opportunities to treat cancers as it is highly associated with cancer progression and immunosuppressive microenvironment. However, traditional regimens using nonselective small-molecule immunomodulators lead to the off-target adverse effects and insufficient the...
Main Authors: | , , , , |
---|---|
Other Authors: | |
Format: | Journal Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160719 |